ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB Dec. Meeting Includes Biologics Symposium; Epidemiology Center Grant Program Disapproved

November 29, 1985

In Brief: Patent For Semisynthetic Taxol Issued To FL Scientist; Simone To Chair Pediatric Group

June 7, 1991

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

WHO Names Brinker As Goodwill Ambassador

May 29, 2009

DCPC Board Approves Concept for New Nutrition Grants

February 10, 1989

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976